The median disease-free survival was 25.6 months in the nivolumab arm and 8.5 months in the placebo arm. Adjuvant nivolumab can improve disease-free survival (DFS) and overall survival (OS) in ...

This important study shows a significant role for Musashi-2 (Msi2) in lung adenocarcinoma. The authors provided solid data that support the requirement for Msi2 in tumor growth and progression, ...

Menteri Kewangan II, Datuk Seri Amir Hamzah Azizan berkata, penyasaran subsidi petrol RON95 yang bakal dilaksanakan sama seperti diesel yang mengambil kira harga pasaran. Bagaimanapun, katanya, ...

Households are being encouraged to consider a fixed price deal on their energy bills by the regulator ahead of costs rising again in April. Ofgem is increasing the energy price cap by 6.4% ...

The NHCP is responsible for promoting Philippine history through its museums, research, and publications, as well as preserving historical heritage by conserving and marking historic sites and ...

The LA City Council passed an amendment to the Just Cause for Eviction Ordinance (JCO), which went into effect January 27, 2025. It applies to most landlords who own and lease residential property ...

QUEZON CITY, (PIA) — The Bureau of Immigration (BI) has intensified its crackdown on illegal Philippine Offshore Gaming Operators (POGOs), resulting in 518 arrests and 121 deportations since the ...

“Jadi pemilik persendirian, termasuk yang keretanya tak terjejas, kena bayar kepada syarikat kapal mengikut nilai 60% harga kereta. Banyaklah kami kena bayar. “Klausa GA tersebut, tidak pasti ...

Patients with advanced cancer often experience bothersome symptoms requiring specialist palliative care input. Oncology clinical trials commonly include a list of prohibited medications while on trial ...

The JCO Podcast also features in depth summaries and interviews hosted by the year’s fellows in the series, JCO Article Insights. For information on reuse rights to podcasts, please contact Wolters ...

JCO Precision Oncology Conversations features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they ...